story of the week
TAS-102 for Refractory Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
N. Engl. J. Med 2015 May 14;372(20)1909-1919, RJ Mayer, E Van Cutsem, A Falcone, T Yoshino, R Garcia-Carbonero, N Mizunuma, K Yamazaki, Y Shimada, J Tabernero, Y Komatsu, A Sobrero, E Boucher, M Peeters, B Tran, HJ Lenz, A Zaniboni, H Hochster, JM Cleary, H Prenen, F Benedetti, H Mizuguchi, L Makris, M Ito, A OhtsuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.